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Background: Few cost-utility studies of child and adolescent mental health services (CAMHS) use quality adjusted
life years (a combination of utility weights and time in health state) as the outcome to enable comparison across
disparate programs and modalities. Part of the solution to this problem involves embedding preference-based
health-related quality of life (PBHRQOL) utility instruments, which generate utility weights, in clinical practice and
research. The Child Health Utility (CHU9D) is a generic PBHRQOL instrument developed specifically for use in young
people. The purpose of this study was to assess the suitability of the CHU9D as a routine outcome measure in
CAMHS clinical practice.
Methods: Two hundred caregivers of children receiving community mental health services completed the CHU9D
alongside a standardised child and adolescent mental health measure (the Strengths and Difficulties Questionnaire –
SDQ) during a telephone interview. We investigated face validity, practicality, internal consistency, and convergent
validity of the CHU9D. In addition, we compared the utility weights obtained in this group with utility weights from
other studies of child and adolescent mental health populations.
Results: Participants found the CHU9D easy and quick to complete. It demonstrated acceptable internal consistency,
and correlated moderately with the SDQ. It was able to discriminate between children in the abnormal range and
those in the non-clinical/borderline range as measured by the SDQ. Three CHU9D items without corollaries in the SDQ
(sleep, schoolwork, daily routine) were found to be significant predictors of the SDQ total score and may be useful clinical
metrics. The mean utility weight of this sample was comparable with clinical subsamples from other CHU9D studies, but
was significantly higher than mean utility weights noted in other child and adolescent mental health samples.
Conclusions: Initial validation suggests further investigation of the CHU9D as a routine outcome measure in CAMHS is
warranted. Further investigation should explore test-retest reliability, sensitivity to change, concordance between caregiver
and child-completed forms, and the calibration of the utility weights. Differences between utility weights generated by
the CHU9D and other utility instruments in this population should be further examined by administering a range of
PBHRQOL instruments concurrently in a mental health group.
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Routine outcome measurement in mental health services
involves the use of generic measures to assess change in
consumers’ functioning, performance or participation
over time [1,2]. Routine outcome measurement serves
multiple purposes. At the consumer level, measures can
be used to monitor therapy progress and foster dialogue
about treatment goals. Clinicians and supervisors can
use measures for reflective practice, to choose appropri-
ate treatments, to determine eligibility for treatment,
and for discharge planning. Services can use aggregated
data from measures for quality improvement activities
and to foster evidence-based practice. Finally, funders
and policy makers can use data aggregated from services
to make decisions about resource allocation [1-4].
In Australian child and adolescent mental health services
(CAMHS), 2 instruments are commonly used to track out-
comes during a clients’ episode of care. The Health of the
Nation Outcome Scales for Children and Adolescents
(HONOSCA) is a clinician-completed 15-item measure of
a child’s symptoms and social and physical functioning [5].
The Strengths and Difficulties Questionnaire (SDQ) is a
caregiver- or child/adolescent-completed 25-item brief be-
havioural screening questionnaire [6]. The 2 measures are
complementary. The HONOSCA supports clinicians in
rating a child’s functioning across important diagnostic and
functional domains. The HONOSCA can be used at the
individual level to guide treatment decisions, but also at
the organisational level to profile the population receiving
care. The SDQ provides an opportunity for young people
or caregivers to rate emotional and behavioural symptoms
to track progress during intervention. In both cases, when
used at more than 2 time points during an episode of care,
the instruments can be used to monitor the outcomes of
intervention.
In a previous paper we recommended that CAMHS
consider integrating preference-based health-related
quality of life (PBHRQOL) instruments into routine out-
come measurement practice [7]. Health-related quality
of life refers to an individual’s perception of their phys-
ical and mental health and thus PBHRQOL instruments
are used to rate an individual’s functioning across a
range of domains (e.g. Independent Living, Happiness,
Mental Health, Coping, Relationships, Self Worth, Pain,
Sensation). In contrast to the SDQ and HONOSCA which
are mental health focused, PBHRQOL instruments are
commonly generic, assessing domains relevant to individ-
uals with many types of illness.
PBHRQOL instruments are unique amongst standar-
dised instruments in that they generate utility weights.
Utility weights have significant value in health policy,
as they are used to calculate what is known as ‘quality-
adjusted life-years’ (QALY), a measure of health used
in the evaluation of health-related interventions. Thevalue of the QALY is that it can capture both quality of
life, and life expectancy effects as a result of interven-
tion, and its generic form facilitates comparison of the
cost-effectiveness of health interventions from diverse
areas. The QALY is now the standard outcome measure
in health economic evaluation and used by key national
health bodies such as the National Institute of Health
and Care Excellence (NICE) in the UK, and the
Pharmaceutical Benefits Advisory Committee (PBAC)
and Medical Services Advisory Committee (MSAC) in
Australia. This is an important point. In health, where
there are limited budgets, those services/programs/inter-
ventions that can demonstrate their benefits using metrics
employed by key policy advisory groups, increase their
chances of funding. This is the primary logic behind our
recommendation for these metrics to be embraced by
mental health services, which compete, at least partially,
with pharmaceuticals for funding. Pharmaceutical com-
panies are well versed in using these metrics to show the
benefits of their products.
Utility weights are calculated by applying a special
algorithm or tariff to an individual’s responses on the
PBHRQOL instrument. These tariffs are derived from a
valuation process in which members of the general
population rank between 0 (representing death) and 1
(representing full health), the different health states de-
scribed by the instrument. In practice, ranking all the
health states is impossible. A 9-item instrument like the
CHU9D discussed in this paper, can generate almost
2,000,000 health states (9 items, 5 levels each - 59).
Health economists use specialised modelling to predict
utility weights for all the different health states, by ob-
serving the population’s response to a subset of them.
There are different valuation processes (e.g. standard
gamble, time-trade off ) and modelling methods [8]. As
such, a single instrument may have different tariffs for
different population groups that are used to generate
utility weights. For example, the CHU9D has 2 tariffs—
a UK Adult Tariff [9] and an Australian Adolescent
Tariff [10].
There is a growing range of PBHRQOL instruments
available for use with children and adolescents includ-
ing the Health Utilities Index (HUI) [11], 16D and 17D
[12,13], EQ-5D-Y [14], Adolescent Health Utility
Measure (AHUM) [15] and the Assessment of Quality
of Life – 8 Dimension (AQoL-8D) [16]. They range in
size from the 5-item, 5-dimension EQ-5D-Y to the 35-
item, 8-dimension AQoL-8D. They also range in scope
from the AQoL-8D and AHUM which are suitable for
use in adolescents to the HUI which can (with proxy
measurement) be used in children as young as 5. A
relatively new instrument called the Child Health Utility –
9D (CHU9D) has been the subject of a number of recent
publications [17-25].
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The CHU9D [17-20] was designed for use in children
aged 7–11 years, but with interviewer assistance can be
used in children as young as 6 [21], and research has
demonstrated its validity in adolescents up to age 17
[22]. It consists of 9 items, each with 5 response categor-
ies (scored 1–5) that assess the child/adolescent’s func-
tioning “today” across domains of worry, sadness, pain,
tiredness, annoyance, school, sleep, daily routine and ac-
tivities. The instrument is available in both self-report
(completed by the child) and proxy-report (caregiver
completed) forms.
The CHU9D was developed in response to a per-
ceived paucity of paediatric preference-based measures
for use in health care resource-allocation decision mak-
ing [17]. The 9 domains of the questionnaire were iden-
tified from qualitative interviews with children aged 7
to 11 years, who described the areas of their life
affected by their health conditions [18]. As with other
PBHRQOL instruments, the CHU9D has undergone
‘valuation’ where the various health states described by
the instrument (i.e. potential combination of scores
across the different items) have been valued by the gen-
eral public generating tariffs for calculating utility
weights from an individual’s score [9]. In fact, 2 sets of
preference weights (tariffs) are available. The first (UK
Adult Tariff ) was generated from health state valuation
interviews with 300 members of the UK adult general
population [9] using the standard gamble method. This
tariff generates utility weights between .33 and 1. The
second set (Australian Adolescent Tariff ) was developed
by Ratcliffe and colleagues [10], based on interviews with
590 Australian adolescents using profile case best-worst
scaling (BWS) discrete-choice experiment (DCE) methods.
It similarly generates values between .33 and 1, although
demonstrates some significant differences in the valuation
of some health states, particularly related to mental health
attributes [22].
There are a number of features of the CHU9D that
make it a potential candidate as a routine outcome
measure in child and adolescent mental health. It was
developed using research with children, is brief and sim-
ply worded, has a low response burden, is available in
proxy and self-report forms, has been used in children
and adolescents from 7–18 years old, uses a shortened
reference time frame (“today”) suitable for repeated mea-
surements, has a good representation of mental health
related items (sad, worried, annoyed), and is impact ra-
ther than symptom focused, complementing existing
measures. Previous validation studies with adolescents
from the community have found the instrument to be
well understood, to discriminate between individuals
based on their self-reported health status and show ex-
pected correlations with other generic quality of lifeinstruments [22,24]. A validation study with children
aged 6–7 [21] showed they appeared to comprehend the
questions when asked by an interviewer, but there was
some doubt as to the reliability of their answers, given
relatively low test-retest reliability. Validation studies
with clinical populations have not been carried out to
our knowledge.
Our own unpublished pilot testing of the CHU9D with
children, caregivers and CAMHS providers indicated
that children as young as 6 could complete the instru-
ment with assistance, that caregivers found the instru-
ment brief and simple to use, and providers felt the
instrument provided a reasonable overview of the child’s
functioning. There was also correlational evidence that a
young person’s score on the CHU9D (either self-report
or proxy) corresponded with their clinical severity as in-
dicated by the service provider.
The purpose of this paper is to report on the findings
of using the proxy version of the CHU9D alongside the
widely-used Strengths and Difficulties Questionnaire
(SDQ) with 200 caregivers of children receiving mental
health services. As our aim was to determine whether
the CHU9D would make a suitable instrument for use in
CAMHS, we explored multiple aspects of its perform-
ance: face validity, practicality, internal consistency, and
convergent validity. We also compared the utility
weights obtained in this child and adolescent mental
health population, with utility weights from other studies
of child and adolescent mental health populations.Method
Design
The study employed a cross-sectional telephone survey
design, in which caregivers of children receiving services
from a local child and adolescent mental health service
were asked to complete the CHU9D and the SDQ in a
single sitting. The study was approved by both Health
Service (#384.11) and University ethics committees
(#25739).
In this study, we sought to answer 5 questions about
the CHU9D, relevant to its potential use as a routine
outcome measure in CAMHS. These are summarised in
Table 1.Participants
Participants were parents or other adult relatives of chil-
dren aged 5–17 years (inclusive), who were registered as
‘current clients’ of a regional child and adolescent mental
health service. ‘Current client’ status was defined as hav-
ing an open episode of care and a recorded contact
within the last 6 weeks. Excluded were caregivers who
had no recorded telephone number, had specific “no
contact” instructions in the electronic clinical record,
Table 1 Study research questions
Topic Research question Outcome if CHU9D is appropriate for use in CAMHS
Face validity and
practicality
1. Is the CHU9D simple to understand and complete? CHU9D should be well understood and easily completed
by participants.
Reliability 2. What is the internal consistency of the CHU9D? Instrument should have acceptable to excellent internal
consistency indicating the items are tapping into the
same general construct (health-related quality of life).
Convergent validity 3. How do items and scores on the CHU9D correlate with items
and scores from the Strengths and Difficulties Questionnaire (SDQ),
a well-established and widely used routine outcome measure in
child and adolescent mental health?
Items and scores on the CHU9D should demonstrate
predictable and moderate to high correlations with items
and scores on the SDQ, indicating they are tapping into
the same broad construct (psychosocial functioning).
4. Can the CHU9D discriminate between children in the clinical
and non-clinical range on the SDQ?
Scores on the CHU9D should be able to discriminate




5. How do the utility weights from this child and adolescent
mental health sample compare against utility weights obtained
from other child and adolescent mental health samples?
The utility weights that the CHU9D generates for this
mental health population should reflect utility weights
obtained in other similar mental health populations.
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current guardianship or family court orders.
Procedure
Potential participants were identified from the electronic
clinical record of the CAMH service and placed on a list.
The order of participants on the list was randomised be-
fore being provided to telephone interviewers. All listed
participants were sent out introductory letters at least one
week prior to being contacted by phone by interviewers.
Where a participant was identified as having more than
one child receiving CAMH services, a coin toss method
was used to identify which child the participant would be
asked to rate.
Measures
A telephone survey was developed that consisted of the
CHU9D, the SDQ and additional demographic, present-
ing issue, and service satisfaction questions. The order
of presentation was the same for all participants. Child
health status and emotional and behavioural health were
assessed by proxy (i.e. by the child’s caregiver). Proxy
outcome measurement is common practice both in
CAMH services and quality of life studies where seeking
self-report from children can be compromised by age
and comprehension issues.
Child Health Utility – 9D
The CHU9D, described previously, consists of 9 items
each with a 5-level response category. Each item taps
into a different domain (worry, sadness, pain, tiredness,
annoyance, school, sleep, daily routine and activities).
The time frame for the questions is “today”. Because of
this, we asked a sub-sample of participants an additional
question of whether “today” was a typical day for the
child, to determine the representativeness of the child’s
functioning on that day, of their general functioning. Incases where participants struggled to rate their child’s
behaviour on that day, we asked them to rate their
child’s behaviour on an average day. In examining the
performance of the CHU9D, we present utility weights
using both available tariffs, the UK Adult Tariff and the
Australian Adolescent Tariff. Completed CHU9D ques-
tionnaires were scored using SPSS syntax provided by
the authors of the tariffs [10,17].
Strengths and Difficulties Questionnaire
The Strengths and Difficulties Questionnaire (SDQ) [6]
was first developed as a shorter alternative to behav-
ioural screening questionnaires such as the Rutter [26]
and Child Behaviour Checklist [27,28] but with an add-
itional focus on young people’s “strengths”. The SDQ
has repeatedly demonstrated equivalence to these longer
measures in terms of factor structure, reliability, sensitiv-
ity to detecting psychiatric diagnoses, and sensitivity to
change [29-31]. The instrument is now a widely-used
mental health screening measure in children and adoles-
cents aged 4–17 years. In fact the SDQ is now a man-
dated consumer self-report routine outcome measure in
Australian CAMHS [32], and a standard measure in UK
routine outcome collections [33].
The SDQ comprises 25 items, each describing a psycho-
logical or behavioural attribute (some positive, some nega-
tive) which the responder indicates as being “very true”,
“somewhat true” or “not true” of the child/adolescent in
question over the last 6 months. The instrument generates
both a total score and scores for 5 subscales including
emotional, conduct, hyperactivity-inattention, peer prob-
lems and prosocial behaviour. The total score ranges from
0–40 with higher values indicating greater behavioural and
emotional pathology. Individual sub-scales are scored from
0–10 with higher scores indicating poorer functioning for
four of the subscales (emotional, conduct, hyperactivity-
inattention and peer problems), and better functioning for
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scores available for the sub-scales and the total score that
define the following clinical bands: normal, borderline and
abnormal. These are based on a population-based UK sur-
vey in which cutoffs were chosen such that 80% of children
scored normal, 10% scored borderline and 10% scored ab-
normal. The SDQ is available in 3 forms - adolescent self-
report, caregiver-administered and teacher-administered.
We used the caregiver-administered form in this study and
utilised SPSS syntax from the SDQ website [34] to score
the instrument. The impact supplement was not used in
this study.
Crossover between measures
Only the 3 emotionally-related items (worried, sad,
annoyed) in the CHU9D have obvious corollaries in the
SDQ (Table 2). Furthermore the 2 instruments ask about
quite different reference periods: the CHU9D asks about
the child’s functioning ‘today’ whilst the SDQ asks about
the previous 6 months.
Analysis
Analyses were conducted using SPSS Version 19 and
according to the following procedure:
1. Data was screened and cleaned. There was 1 missing
CHU9D data point and 26 missing SDQ data points.
Two SDQ items (“kind to younger children” and
“steals”) were the most frequently missed and
comprised 9 data points in total, whilst other
missing data points were scattered across the
remaining 23 items. Missing data represented just
0.4% of all data items. A review of the raw SDQ
questionnaire data revealed caregivers commonly
reported “don’t know” on these items. For analysis
purposes, a “no problem” approach was taken where
missing values for these data points were replaced
with the equivalent value for no problem. For the 1Table 2 Mapping of CHU9D items to SDQ items
CHU9D items
How worried is your child today?
How sad is your child today?
How much pain does your child have today?
How tired is your child today?
How annoyed is your child today?
How is your child doing with their schoolwork/homework today?
How did your child sleep last night?
How is your child doing with their daily routine today?
To what extent can your child join in with activities today?missing CHU9D item, the same “no problem”
approach was taken.
2. Descriptive statistics such as age and gender were
tabulated.
3. SDQ subscale and total scores were calculated using
syntax available from the SDQ website [34].
4. CHU9D raw scores were calculated and translated
into utility weights using the original UK Adult
Tariff [17] and the Australian Adolescent Tariff [10].
5. CHU9D raw and utility weights were tabulated and
divided by respondent characteristics.
6. Research Question 1 (face validity and practicality)
was addressed by comparing the proportion of
missing items from the CHU9D with the SDQ. We
also utilised qualitative information collected by
interviewers during the study on which questions
caused the most difficulties for respondents in
answering.
7. Question 2 (reliability) was addressed by calculating
Cronbach’s alpha for the CHU9D. Given that the
CHU9D items tap into the same overall construct
(quality of life) but represent different domains, we
set an alpha of 0.7 as a minimally acceptable level of
internal consistency [35].
8. Question 3 and 4 (convergent validity) were
addressed as following:
a. We calculated Pearson’s product moment correlations
between the CHU9D utility weight (both tariffs) and
the SDQ total score. We used Cohen’s [36]
categorisations to describe the strength of the
correlation (0.1 = small, 0.3 = moderate, 0.5 = large).
b. We generated an item-level correlation matrix of
CHU9D and SDQ items to look for correlations
between items, particularly those that were
conceptually related.
c. We regressed the SDQ total score on the
individual items of the CHU9D using simple linear
regression with all CHU9D items enteredCorresponding SDQ items
Many worries or often seems worried
Nervous or clingy in new situations, easily loses confidence
Many fears, easily scared








Table 3 Descriptive characteristics of participating
caregivers and their children
Participants
(N = 200)













First time with CAMHS, %
Yes 74.5
No 25.5
Length of time with CAMHS for current
Episode (months), mean (SD)
11.95 (16.6)
Strengths and Difficulties Questionnaire (SDQ)
Total score, mean (SD) 19.52 (7.87)
Emotion Subscale, mean (SD) 5.40 (2.55)
Conduct Subscale, mean (SD) 4.01 (2.86)
Hyperactivity Subscale, mean (SD) 6.41 (2.81)
Peer Subscale, mean (SD) 3.71 (2.43)
Prosocial Subscale, mean (SD) 6.92 (2.23)




CHU9D Raw score, mean (SD) 18.51 (6.64)
CHU9D Raw score, median (IQR) 17.00 (13–23)
CHU-9D Utility score
UK Adult Tariff, mean (SD) 0.803 (.117)
Australian Adolescent Tariff, mean (SD) 0.739 (.145)
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determine the variance in SDQ scores explained
by the CHU9D. We used significance on B values
to determine which CHU9D items were most
predictive of SDQ Total scores.
d. CHU9D utility weights were tabulated by respondent
characteristics; age, gender, SDQ clinical band.
e. Mann-Whitney U and Kruskal-Wallis tests were
used to test for differences between groups based on
these respondent characteristics. Non-parametric
tests were used because CHU9D utility weights were
not normally distributed. A difference of ≥ .03 in
utility scores was considered clinically significant
based on Drummond’s [37] ‘rule of thumb’.
9. Question 5 (validity of utility weights) was addressed
by comparing the mean utility weights (both tariffs)
from the current sample against mean utility
weights from (a) other studies using the CHU9D,
and (b) other utility studies of child and adolescent
mental health populations.
Results
A total of 900 participants met the inclusion criteria
during the data collection period and were randomised
for contact. Interviewers attempted to contact caregivers
by moving sequentially through the list of caregivers
until 200 interviews were completed. This resulted in
407 caregivers being approached, of whom 150 were not
contactable, 37 declined to be interviewed, 14 were dis-
covered not to meet the criteria and 6 interviews were
not completed. Descriptive statistics for the full sample
(missing data imputed) are presented in Table 3.
Three-quarters of participants were first-time CAMHS
clients. Most (87%) participants were mothers. Based on
SDQ scoring guidelines for total problems, 132 of the
children were in the clinical range (66%), 24 were in the
borderline range (12%) and 44 were in the normal range
(22%). The proportion of children with scores indicating
clinically significant problems in specific domains were
as follows: emotional problems (60%), conduct problems
(51%), hyperactivity (51%), peer problems (50%) and pro-
social (17%). Two-thirds of children had difficulties in 2
or more areas and almost 30% of children had difficul-
ties in 4 or more areas.
Consistent with it being a clinical sample, the mean
SDQ total score was in the clinical range, and emotion,
conduct, hyperactivity and peer subscales were all con-
siderably higher (i.e. worse) than published Australian
norms collected from parents of children in a similar
age bracket (7–17) [38].
Weights from the UK Adult Tariff (Mdn = .819) were
significantly higher than those from the Australian Ado-
lescent Tariff (Mdn = .746), T = 743, p = .000. In fact,
87% of participants had a higher utility weight whenusing the UK Adult Tariff compared to the Australian
Adolescent Tariff. The distributions of utility weights
from the 2 tariffs are shown in Figure 1.Question 1 – face validity and practicality
Interviewers reported that the CHU9D proxy was simple
and quick to administer, typically taking less than 2 mi-
nutes to complete. There was only one missing CHU9D
data point across the 200 participants, indicating the
Figure 1 Distribution of CHU9D utility weights for UK and Adolescent Tariffs.
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proxies.
Ninety (90) participants were asked if “today” (the
reference time frame for the CHU9D) represented a
typical day in terms of the child’s behaviour. This ques-
tion was added to the survey after some parents re-
ported the child’s behaviour during the survey period
to not be representative of their general behaviour.
Twenty-nine (32%) reported ‘no’ suggesting 1/3 of
CHU9D ratings might not accurately capture the child’s
average level of functioning. Of these 29, 18 (62%) indi-
cated that today was ‘better than usual’ indicating a
very subtle bias at the group level for the caregiver-
completed CHU9D to underestimate dysfunction in
some children.
Another issue encountered by interviewers was that 3
parents struggled to answer the typical day question be-
cause of limited exposure to their child that day and
hence lack of knowledge about their mood, sleep, school
and daily routine.Figure 2 Scatterplot of CHU9D utility weights and SDQ scores by TarQuestion 2 – internal consistency
The Cronbach alpha for the CHU9D was .781, indicating
an acceptable level of internal consistency.
Questions 3 and 4 – convergent validity
Figure 2 shows the scatterplot of CHU9D utility values
(UK Adult and Australian Adolescent tariffs) and SDQ
Total scores. Utility weights were moderately correlated
with the SDQ total score, for both the UK Adult Tariff
[r(199) = −.487 (p < .001)] and Australian Adolescent
Tariff [r(199) = −.494 (p < .001)].
The correlation matrix of CHU9D and SDQ items
(Table 4) revealed a predictable pattern. The strongest
correlations were between the utility weights and the
SDQ total score. The strongest item-level correlations
were generally between conceptually overlapping items
(e.g., ‘many worries’ on SDQ and ‘worried’ on CHU9D,
or ‘often unhappy’ on SDQ and ‘sad’ on CHU9D). The
directions of the correlations were all in expected
directions.iff.


























SDQ considerate .043 .007 .054 -.059 -.170* -.233** -.031 -.190** -.169* .151* .119
SDQ restless .089 .148* .040 .113 .267** .140* .144* .181* .096 -.242** -.242**
SDQ sickness .191** .182** .196** .260** .169* .108 .275** .214** .178* -.314** -.315**
SDQ shares -.066 -.055 -.066 -.043 -.081 -.144* -.155* -.037 -.161* .136 .121
SDQ loses temper .204** .180* -.064 .180* .324** .290** .188** .248** .178* -.327** -.342**
SDQ pref solitary .018 .183** .063 .084 .125 .217** .209** .201** .168* -.233** -.207**
SDQ well behaved -.041 -.146* .148* -.138 -.261** -.294** -.263** -.338** -.292** .332** .317**
SDQ many
worries
.414** .292** .260** .209** .309** .033 .269** .012 .076 -.321** -.364**
SDQ help others
if hurt
-.014 -.026 .052 -.007 -.111 -.120 -.022 -.186** -.279** .173* .116
SDQ fidgeting .064 .173* .019 .065 .226** .159* .169* .218** .174* -.255** -.242**
SDQ one good
friend
-.112 -.121 .008 -.087 -.232** -.060 -.216** -.221** -.216** .254** .261**
SDQ often fights
or bullies
.076 .051 .007 .117 .298** .219** .095 .151* .099 -.227** -.218**
SDQ often
unhappy
.217** .334** .076 .107 .305** .079 .293** .061 .184** -.296** -.318**
SDQ generally
liked by others
-.077 -.070 .087 -.100 -.153* -.176* -.071 -.239** -.197** .187** .167*
SDQ easily
distracted
.134 .148* -.074 .130 .235** .322** .135 .220** .247** -.290** -.264**
SDQ low
confidence
.183** .156* .104 -.010 .143* .054 .054 .020 .096 -.129 -.125
SDQ kind to
younger children
.000 -.047 -.003 -.075 -.188** -.148* -.104 -.138 -.144* .191** .162*
SDQ often lies/
cheats
.076 .151* -.031 .123 .282** .272** .193** .188** .230** -.286** -.272**
SDQ picked on or
bullied
.170* .198** .085 .127 .231** .005 .167* .099 .165* -.252** -.257**
SDQ volunteers to
help
.000 -.053 -.069 -.035 -.062 -.233** -.009 -.127 -.219** .163* .124
SDQ thinks before
acting
-.045 -.067 .126 -.106 -.193** -.291** -.155* -.217** -.252** .228** .196**
SDQ steals .016 .108 -.034 .113 .144* .234** .152* .341** .171* -.247** -.223**
SDQ better with
adults than peers
.217** .105 .091 .114 .118 .128 .198** .028 .216** -.211** -.215**




.014 -.041 .083 -.077 -.109 -.436** -.084 -.243** -.126 .230** .171*
SDQ Total .250** .305** .049 .235** .424** .368** .351** .350** .352** -.506** -.497**
**correlation is significant at the .01 level (two-tailed).
*correlation is significant at the .05 level (two-tailed).
Bolded figures are those where CHU9D and SDQ items have clear conceptual overlap.
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CHU9D items (Table 5) revealed that the 9 CHU9D
items explained 31.5% of the variance in SDQ total
scores. Four items: annoyed, schoolwork, sleeping and
daily routine, emerged as significant predictors.Table 6 summarises mean (SD) and median (IQR)
CHU9D weights according to respondent characteristics.
Utility weights did not differ between age bands, or
based on gender or first time with CAMHS. Utility
weights did however decrease linearly with increasing
Table 5 Linear regression predicting SDQ total score from
CHU9D items
B (95% CI) SE B β p
Constant 8.22 (5.35, 11.094) 1.46 .000
CHU9D worried .668 (−.213, 1.548) .446 .109 .136
CHU9D sad -.103 (−1.18, .973) .545 -.015 .851
CHU9D pain -.385 (−1.44, .673) .537 -.047 .474
CHU9D tired -.476 (−1.27, .313) .400 -.083 .236
CHU9D annoyed 1.355 (.472, 2.24) .448 .238 .003
CHU9D schoolwork .943 (.249, 1.64) .352 .174 .008
CHU9D sleep 1.533 (.651, 2.41) .447 .232 .001
CHU9D daily routine 1.194 (.136, 2.25) .537 .155 .027
CHU9D activities .766 (−.218, 1.75) .499 .107 .126
Note: R2 = .346, Adjusted R2 = .315.
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idity. Post hoc tests revealed those in the abnormal band
had significantly lower utility weights than those in the
borderline and normal bands.
Question 5 – comparisons of utility weights
Mean utility weights were lower in this study than for 2
Australian community samples (aged 11–17) tested
using the CHU9D self-report version [22,24]. Further-
more, utility weights in this sample were lower than the
only published utility norms for this age range (0.90 to
.92 — Canadian norms using Health Utilities Index [39])
consistent with the sample being taken from a clinical
population.Table 6 CHU9D weights by respondent characteristics









Total group 200 (100) .803 (.117) .739 (.145) .819 (.731
Age – 5-12 118 (59) .813 (.108) .744 (.143) .828 (.743
Age – 13-18 82 (41) .790 (.127) .731 (.148) .812 (.716
Gender male 105 (52.5) .805 (.113) .746 (.137) .825 (.748
Gender female 95 (47.5) .801 (.121) .731 (.153) .801 (.716
SDQ Clinical
Band
Normal 44 (22%) .877 (.072) .839 (.106) .878 (.821
Borderline 24 (12%) .852 (.102) .793 (.139) .869 (.770
Abnormal 132 (66%) .770 (.117) .696 (.138) .787 (.698
First time with
CAMHS
Yes 149 (74.5) .807 (.120) .743 (.149) .822 (.729
No 51 (25.5) .793 (.107) .727 (.134) .813 (.733There were few studies of mental health populations
against which to compare the values obtained in this
study. For the few studies available [40-43], mean utility
values were considerably higher in our study (e.g. .739
and .803 compared with .468, .433, .432, .656 and .49).
Comparisons between studies should be treated with
caution however as different instruments were utilised
(HUI3 and EQ-5D) and the populations are not neces-
sarily comparable. Details of the comparisons are sum-
marised in Table 7.Discussion
Health economic evaluations are routinely using the QALY
as a summary measure of health outcome. The value of the
QALY is that it is a generic measure that enables compari-
sons between a diverse range of health services, programs
and interventions. In a health system where budgets are
limited but demand for health services is high, policy
makers need to make decisions about what services, pro-
grams and interventions to fund. Consideration of cost per
QALY is a key part of this decision making process [44].
In this context psychotherapy-based services such as
specialist CAMHS are competing for resources against
pharmaceutical companies who have developed medica-
tions for many of the conditions seen in CAMHS (e.g.
methylphenidate for ADHD, antidepressants for depres-
sion and anxiety) and are seeking to have those medica-
tions included in pharmaceutical benefits schemes.
Whilst pharmaceutical companies are well versed in the








-.894) U = −1.021, P = .307 .740 (.646-.862) U = −.596, P = .307
-.875) .752 (.604-.856)
-.878) U = −.352, P = .725 .762 (.645-.855) U = −.669, P = .503
-.898) .740 (.592-.862)
-.939) H(2) = 35.50, P = .000 .872 (.760-.925) H(2) = 35.84, P = .000
-.943) .830 (.661-.918)
-.859) .702 (.584-.810)
-.901) U = −1.01, P = .311 .760 (.624-.872) U = −.817, P = .414
-.861) .715 (.644-.822)
Table 7 Comparison of utility weights from the current study with other mental health populations
Reference Population Instrument Utility
Current study 200 5–17 year olds with varied mental
health presentations
CHU9D parent completed –
UK adult tariff
.803 (.117)
200 5–17 year olds with varied mental
health presentations




Stevens and Ratcliffe 2012 [9,10] Community sample of 961 11 to 17 year olds CHU9D self-report, web survey –
UK tariff
.85
Sub-sample of 67 with long-standing disability,
illness or medical condition
CHU9D self-report, web survey –
UK tariff
.80
Sub-sample of 281 with score on KIDSCREEN
below the median
CHU9D self-report, web survey –
UK tariff
.789
Ratcliffe et al. 2012 [24] Community sample of 710 11 to 17 year olds CHU9D self-report, web survey –
UK tariff
.931
Other studies of mental health populations
Petrou & Kupek 2009 [41] 46 children (mean age 10.9) on a disability
registry with behaviour disorders
HUI3 – caregiver completed .468
105 children (mean age 11) on a disability
registry with autism spectrum disorder
HUI3 – caregiver completed .433
50 children (mean age 10.9) on a disability
registry with hyperactivity disorders
HUI3 – caregiver completed .432
Petrou et al. 2010 [40] 39 children (aged 11) from a longitudinal
study of pre-term infants
HUI3 – caregiver completed .656
Goodyer et al. 2008 [42] 200 11–17 year olds with depression prior
to SSRI therapy
EQ-5D .49
Bodden et al. 2008 [43] 59 children with anxiety disorders prior to
receiving individual CBT
EQ-5D .87
57 children with anxiety disorders prior to
receiving family CBT
EQ-5D .83
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for submissions to the Pharmaceutical Benefits Advisory
Committee [45], there are relatively few cost-utility studies
of psychotherapy interventions and the use of PBHRQOL
instruments in CAMHS is rare. For example, a search on
“utility” in the PEDE database [46] returned 173 cost-
utility studies, of which only 12 were for child and adoles-
cent mental health disorders and 9 of these were for
pharmaceutical treatments. This state of affairs disadvan-
tages psychotherapy-based CAMHS who lack QALY data
to support the effectiveness of their interventions.
In this study we explored the potential value of the
Child Health Utility (CHU9D) as a routine outcome meas-
ure for use in CAMHS. The CHU9D is a preference-based
instrument that generates utility weights which can be
used to calculate QALYs for use in health economic evalu-
ations. Of particular interest was whether the CHU9D was
quick and easy to use, whether it could act as a suitable
proxy for mental health symptoms, and whether it gener-
ated utility weights similar to those measured in other
child and adolescent mental health population studies.
From a clinical perspective, the CHU9D was quick and
easy to administer, and caregivers had little troubleanswering the questions, suggesting it could be imple-
mented with minimal fuss for caregivers. Three of the in-
strument’s 9 items relate directly to emotional symptoms:
worried, sad, and annoyed. Additionally, the 3 items that
were found to be significant predictors of the SDQ total
score — schoolwork, sleep, and daily routine — measure
impacts in areas commonly disrupted in children with a
wide variety of mental health disorders. In a recent study
of clinician’s behaviour and attitudes towards routine out-
come measurement, administrative load and instrument
relevance were highlighted as barriers to implementation
[47]. The brevity and broad clinical relevance of the
CHU9D are therefore important when considering the
likelihood of clinicians endorsing and taking up the instru-
ment in clinical practice.
Two administration issues were identified and need to
be explored further. The first is that the instrument asks
about the child’s functioning ‘today’. Almost 1/3 of care-
givers in our study reported that ‘today’ was not a typical
day for the child which may have led some to underesti-
mate their child’s dysfunction. The other finding was
that a small number of parents were unable to rate the
child’s functioning that day due to limited exposure to
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rated parents to share access to their child, this issue
may occur more frequently than in non mental health
populations. We suggest one modification to the instru-
ment which might help address this problem, subject to
further testing. This is to adjust the wording for care-
givers to rate a ‘typical day’ if they report not having the
information required to answer for the actual day in
question.
Psychometrically, the instrument performed adequately,
although we were only able to test a couple of aspects of
its performance. The obtained Cronbach alpha of .781 is
challenging to interpret. On one hand, it compares
favourably to the alpha of .66 found by Foster Page et al.
[48], suggesting the items are converging better in a men-
tal health population than in a dental population. It was
also higher than our cutoff of 0.7 but not in high 0.9’s sug-
gesting the items are tapping into a central construct (i.e.
quality of life) without indicating some items are redun-
dant. However, it is difficult to define an ideal value for
alpha for an instrument that is designed to measure the
multi-dimensional nature of quality of life in children. We
expect that further validation exercises in clinical popula-
tions with samples large enough for factor analysis will
help illuminate the factor structure of the instrument for
different clinical populations.
In terms of validity, despite having a different focus
and reference time period to the SDQ (today vs last 6-
months), there was evidence of moderate convergence
between the instruments. The correlation between the
SDQ and the CHU9D was in the moderate to strong
range, item-level correlations were in the expected direc-
tion, and children in the abnormal range on the SDQ
showed significantly lower utility weights than children
in the borderline/normal ranges. These findings are im-
portant as a predictable relationship between quality of
life and child and adolescent mental health supports the
use of PBHRQOL instruments in this population.
From an economic perspective, we noted two things in
relation to the utility weights generated by the CHU9D
tariffs. First, we noted utility weights from this study
were significantly higher (i.e. indicating better quality of
life) than those collected in other child and adolescent
mental health populations. Whilst the comparison was
highly fraught as the comparative studies used different
instruments and populations, we believe this issue war-
rants further investigation. If competing instruments
generate significantly different utility weights in the
same population, the interpretation of economic evalua-
tions may be influenced by choice of utility instrument
in addition to the performance of assessed interventions,
a finding noted elsewhere [49,50]. Our current hypoth-
esis is that the CHU9D is overestimating quality of life
compared to other instruments in mental healthpopulations, consistent with that found in other CHU9D
studies [24]. The implications for this in terms of choice
of instrument to use in measuring the impact of child
and adolescent mental health interventions needs further
exploring.
Second, we noted the failure of both CHU9D tariffs to
capture the full range of utility weights from 0–1. Both
tariffs have a floor utility weight of .3, similar to that
seen in the SF-6D, a widely used adult utility instrument
[51]. This smaller range can lead to an over-prediction
of utility in poor health states [52] and an underestima-
tion of utility change in intervention studies [53]. Thus
the CHU9D might over-predict utility in severe Child
and Adolescent Mental Health Services presentations,
for example, severe mental illness (schizophrenia,
depression) with suicidal ideation and suicide attempts.
Interventions evaluated using the instrument may also
show smaller utility gains (higher cost-utility estimates),
than might be seen in adult populations where the EQ-
5D is used, which has a significantly wider score range.
Both situations potentially disadvantage economic evalua-
tions of interventions in child and adolescent mental
health, compared to adult interventions. Within the limited
utility range, the Australian Adolescent Tariff generated a
wider spread of scores and consistently lower mean values.
Thus we suggest there is still ongoing work with these
tariffs, to reduce the floor effect and explore differences in
ratings between adolescents and adults. We note for
example that a recent modification of the classification
system of the SF-6D has provided preliminary evidence of
being able to reduce the floor effect [54], and such an ap-
proach may be relevant to the CHU9D.
Limitations
Due to the nature of the study we were unable to test a
number of useful metrics. For example, we were not able
to calculate test-retest reliability or the sensitivity of the
instrument to change in mental health symptoms over
time, having only one measurement point. These are
particularly important metrics, as the value of the
CHU9D for economic evaluation will depend on its cap-
acity to reliably detect change due to intervention, rather
than large natural fluctuations in an individual’s re-
sponses. We were also unable to explore concordance
between caregiver and child self-completed versions of
CHU9D as the telephone survey methodology was not
well suited to collection of responses from children
and adolescents. As a result, we recommend further
psychometric validation of the CHU9D with a focus on
repeated measures and multiple raters (e.g. child, care-
giver, therapist).
In terms of the study sample, although it was drawn
randomly from a list of active CAMHS clients, difficul-
ties in contacting people from the list possibly led to the
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sample. In essence, families who were not contactable
were assumed to have greater dysfunction, although we
did not have data to test this hypothesis. There is also
the question of whether the study sample is representa-
tive of CAMHS clients elsewhere. Comparisons not re-
ported in this paper however show SDQ scores in our
sample compare very similarly to SDQ scores collected
routinely from other Australian CAMHS, hence we have
reasonable confidence that the study sample is at least
fairly representative of clients of CAMHS in Australia.
It should also be noted that there is a broader debate
relating to the use of preference-based quality of life in-
struments in children and adolescents [55]. Concerns in-
clude that the valuation procedures used in defining the
tariffs may not translate well from adult measures to
children and adolescents, the capacity of children to
understand and complete instruments, the accuracy of
proxy raters, the need to consider family interactions in
children’s measures, and the wide variation in utility
weights noted for different childhood disorders from
existing instruments. We also note (and this applies to
adult instruments as well) that tariffs generated in one
population or age group may not be comparable to those
in other populations, further hampering efforts to use
preference-based HRQOL instruments to facilitate cross
comparisons. Whilst it is beyond the scope of this paper
to address these issues in any depth, it should be noted
that there are valid arguments that preference-based in-
struments (as they currently stand) might not be the
best fit for child and adolescent populations, and there-
fore alternative metrics of outcomes with economic
relevance (e.g. school attendance) should be similarly
explored.
Future work
The telephone survey method used in this study proved
to be a viable and efficient way of communicating with
caregivers about the mental health and quality of life of
their children receiving mental health services. The
process, which was separate from their clinical care,
caused minimal disruption to clients and therapists. As
such, this method might be suitable for exploring test-
retest, sensitivity to change, and comparisons between
PBHRQOL instruments. Telephone or web-based survey
methods may also be suitable for tracking adolescents
receiving services. For example, Ratcliffe and colleagues
were able to obtain consent and collect data from ado-
lescents using a web-based survey [24]. Eliciting answers
to the CHU9D from very young children has required
direct contact [21], thus studies involving children as
young as 5 might need to be situated within clinics.
Future studies could thus employ telephone and web-
based survey methods, but with a larger range of utilitymeasures, as well as a follow-up assessment and sub-
samples with repeated measures. Studies looking to obtain
scores from children may need to supplement telephone
and web-based methods with assessments conducted
within the clinical services themselves. Templates for such
studies include the Multi Instrument Comparison Project
[56]. The outcomes of comparing the performance of dif-
ferent utility instruments in children and adolescents
would provide much clearer guidance on whether
preference-based instruments are a suitable addition to
mental health services, and if so, which ones are superior.
Conclusion
In this preliminary exploration of the value of the
CHU9D as a routine outcome measure in child and ado-
lescent mental health services, we demonstrated clinical
relevance, ease of use, and adequate psychometric per-
formance. The results of this study show however that
further validation is required, including how the instru-
ment performs in evaluating change over time and de-
veloping tariffs to ensure the utility weights capture the
full range of functioning observed in this population. Ex-
ploring and evaluating the use of preference-based
health related quality of life utility instruments in
CAMHS remains a priority, as use of such instruments
will be essential for CAMHS to demonstrate effective-
ness and economic salience as a health provider, and
therefore allow such services to compete successfully for
resources, in this climate of budgetary restraint.
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